Simris Group
0.129 SEK -1.53%1 investor is following this company
Simris Group is a biotechnology company. The company is focused on research and development as well as the production of bioactive substances from cultured microalgae, for applications in nutrition, cosmeceuticals, and pharmaceuticals. The company's technology also replaces unsustainable raw materials from endangered species and sensitive marine ecosystems. The first product is omega-3 supplements that are sold under their own brand. Simris Group was founded in 2011 and is headquartered in Hammenhög.
Read moreRevenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
SIMRIS B
Daily low / high price
0.12 / 0.14
SEK
Market cap
44.73M SEK
Turnover
6.99K SEK
Volume
55K
Financial calendar
Interim report
2024-08-14
Interim report
2024-11-13
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
SIX SIS AG, W8IMY | 19.1 % | 19.1 % |
Goldman Sachs & Co. LLC, W9 | 7.1 % | 7.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Bulletin from Simris Group AB (publ)’s Annual General Meeting
Notice of the Annual General Meeting of Simris Group AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools